fda semaglutide shortage resolved february 2025 announcement As of 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A FDA ends semaglutide shortage, closing

Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P (2017) The peritoneum: healing, immunity, and diseases

Rybelsus can cause dizziness through several mechanisms: slowed gastric emptying leading to nausea and reduced food intake, improved glycaemic control potentially causing hypoglycaemia (especially with insulin or sulfonylureas), and modest reductions in blood pressure

Medications Affecting the Gastrointestinal Tract: Semaglutide can slow down the movement of food through your stomach and intestines

In last months newsletter we highlighted a February 6 statement by Commissioner Makary indicating that the agency would take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies